Cost of antianginal drug therapy should be considered in drug selection because of all of the following EXCEPT:

Question

Quizplus · Accepted Answer

The statement "Generic formulations may be cheaper but are rarely bioequivalent" is untrue. Generic drugs are required by law to be bioequivalent to their brand name counterparts. Therefore, cost considerations should not be based on the assumption that generic formulations are inferior. Rather, cost should be considered based on the individual patient's financial situation and insurance coverage. A, B, and D are all valid reasons to consider the cost of antianginal drug therapy in drug selection.

Cost of Antianginal Drug Therapy Should Be Considered in Drug